Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00570 TRAD CHI MED
RTNominal down4.280 -0.020 (-0.465%)
Result Announcements

20/08/2019 09:39

Trad Chi Med (00570) interim net up 13% to RMB859.12m

[ET Net News Agency, 20 August 2019] China Traditional Chinese Medicine Holdings Co.
Limited (00570) said its profit attributable to owners of the company was RMB859.12
million for the six months ended 30 June 2019, a year-on-year increase of 13%. The
earnings per share were RMB17.06 cents. An interim dividend of HK5.72 cents will be
distributed.
The revenue was RMB6.94 billion, a year-on-year increase of 27.02%. The gross profit was
RMB4.19 billion, a year-on-year increase of 42.87%. (RC)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.